Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Andre_AGTC Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1477330488960368642.png) @Andre_AGTC Andre-ACGT

Andre-ACGT posts on X about $kura, $mdgl, stocks, $mlys the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::1477330488960368642/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1477330488960368642/c:line/m:interactions.svg)

- X Week XXXXXX +1.80%
- X Month XXXXXXX -XX%
- X Months XXXXXXXXX -XX%
- X Year XXXXXXXXX +43%

### Mentions: XX [#](/creator/twitter::1477330488960368642/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1477330488960368642/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XXX -XX%
- X Months XXX -XX%
- X Year XXXXX +80%

### Followers: XXXXX [#](/creator/twitter::1477330488960368642/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1477330488960368642/c:line/m:followers.svg)

- X Week XXXXX +0.25%
- X Month XXXXX +1.70%
- X Months XXXXX +13%
- X Year XXXXX +22%

### CreatorRank: XXXXXXX [#](/creator/twitter::1477330488960368642/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1477330488960368642/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1477330488960368642/influence)
---

**Social category influence**
[finance](/list/finance)  XXXX% [stocks](/list/stocks)  XXXX% [currencies](/list/currencies)  XXXX% [countries](/list/countries)  XXXX%

**Social topic influence**
[$kura](/topic/$kura) #1, [$mdgl](/topic/$mdgl) #1, [stocks](/topic/stocks) #2752, [$mlys](/topic/$mlys) #2, [$krys](/topic/$krys) #1, [$bbio](/topic/$bbio) #1, [$rvmd](/topic/$rvmd) #10, [$glue](/topic/$glue) #1, [long term](/topic/long-term) #213, [$zvra](/topic/$zvra) #1

**Top accounts mentioned or mentioned by**
[@wallstsai](/creator/undefined) [@bowtiedbiotech](/creator/undefined) [@maximusholla](/creator/undefined) [@pharmdca](/creator/undefined) [@kingachillese](/creator/undefined) [@andreagtc](/creator/undefined) [@amaymd](/creator/undefined) [@jfais20](/creator/undefined) [@biopharmiq](/creator/undefined) [@antisentiment_](/creator/undefined) [@wshao8](/creator/undefined) [@joserestonva](/creator/undefined) [@viewfromahill9](/creator/undefined) [@oncinvestor](/creator/undefined) [@drrichjlaw](/creator/undefined) [@seedy19tron](/creator/undefined) [@grok](/creator/undefined) [@pjamess69](/creator/undefined) [@jialiangliang](/creator/undefined) [@snupsnus](/creator/undefined)

**Top assets mentioned**
[Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Mineralys Therapeutics, Inc. Common Stock (MLYS)](/topic/$mlys) [Krystal Biotech, Inc. Common Stock (KRYS)](/topic/$krys) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd) [Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix) [Axsome Therapeutics, Inc (AXSM)](/topic/$axsm) [Blueprint Medicines Corporation (BPMC)](/topic/$bpmc) [IDEAYA Biosciences, Inc. Common Stock (IDYA)](/topic/$idya) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [AstraZeneca PLC (AZN)](/topic/$azn) [Xenon Pharmaceuticals Inc (XENE)](/topic/$xene) [Mirum Pharmaceuticals, Inc. Common Stock (MIRM)](/topic/$mirm) [Novartis AG (NVS)](/topic/$nvs) [Novo-Nordisk (NVO)](/topic/$nvo) [Akropolis (AKRO)](/topic/$akro) [Seagen Inc (SGEN)](/topic/$sgen) [Karuna Therapeutics, Inc. Common Stock (KRTX)](/topic/$krtx) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [Synthetify (SNY)](/topic/$sny) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) [Scholar Rock Holding Corporation Common Stock (SRRK)](/topic/$srrk) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Catalyst Pharmaceutical  Inc. (CPRX)](/topic/$cprx) [Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr) [Acadia Pharmaceuticals Inc. (ACAD)](/topic/$acad) [Nuvalent, Inc. Class A Common Stock (NUVL)](/topic/$nuvl) [Corcept Therapeutics Inc. (CORT)](/topic/$cort) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna) [Janux Therapeutics, Inc. Common Stock (JANX)](/topic/$janx) [Tarsus Pharmaceuticals, Inc. Common Stock (TARS)](/topic/$tars) [ATAI Life Sciences (ATAI)](/topic/$atai) [Protagonist Therapeutics, Inc (PTGX)](/topic/$ptgx) [Perpetua Resources Corp. Common Shares (PPTA)](/topic/$ppta)
### Top Social Posts [#](/creator/twitter::1477330488960368642/posts)
---
Top posts by engagements in the last XX hours

"$GLUE X hello (holla is trademarked by @Maximus_Holla) Let's see if they brake XX which is long term resistance Some of my stocks are fighting with this round superstitious number. Typically key to propel the stock to XX $ZVRA $TRVI $KURA and soon $BCYC"  
[X Link](https://x.com/Andre_AGTC/status/1976663776306024630) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-10T14:59Z 6071 followers, 6936 engagements


"$NBIX Long term efficacy and safety data in Huntington's Disease Chorea. It was approved in 2023. These results will potentially help with ramping the drug"  
[X Link](https://x.com/Andre_AGTC/status/1975179816644100235) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-06T12:42Z 6069 followers, 1937 engagements


"@Bios_n_Techs @monaco_biotech $ZVRA confirmed the breakout. Next are $TRVI and $KURA to confirm"  
[X Link](https://x.com/Andre_AGTC/status/1976366816302858475) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-09T19:19Z 6066 followers, XXX engagements


"$NVO aquires $AKRO in 5.2B deal Roche aquired $ETNB in Sep Cardio metabolic space is hot No position in both but the trend can go on hopefully with stock like $MDGL $MLYS $VKTX in which I have solid positions"  
[X Link](https://x.com/Andre_AGTC/status/1976266451595239581) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-09T12:40Z 6066 followers, 1501 engagements


"@EgorBezel Infinion and STmicro are not real competitors bc they don't have the technology. Tariff is an issue we should watch. But XXX% Tariff is not visible"  
[X Link](https://x.com/Andre_AGTC/status/1978316148803330459) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-15T04:24Z 6066 followers, XX engagements


"$KURA has X presentations on ESMO 2025 (Oct 17-21) with KO-2806 FTI (Farnesyltransferase Inhibitor) Mono is just safety. But combo w cabo in RCC may propel the stock if ORR XX% We have X catalysts w KURA - ESMO Oct XX + PDUFA Nov 30"  
[X Link](https://x.com/Andre_AGTC/status/1972289775135768604) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-09-28T13:18Z 6070 followers, 3568 engagements


"$AXSM Executing the long term plan Already X drugs on the market X NDA in the next 2Q - ADA and narcolepcy Sitting solid on #2 in my portfolio. Historically what ever thicket is on #2 got aquitered: $SGEN $KRTX $BPMC $VRNA Let's see if $AXSM can keep the tradition alive"  
[X Link](https://x.com/Andre_AGTC/status/1958902939885416930) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-08-22T14:43Z 6065 followers, 6373 engagements


"$KURA on #ESMO25 Three w farnesyl transferase inhibitor (FTI) KO-2806 w cabozantinib in RCC KO-2806 mono in RAS mutations Tipifarnib and alpelisib in PIK3CA-mutant HNSCC The most interesting are RCC data"  
[X Link](https://x.com/Andre_AGTC/status/1977365797962977673) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-12T13:28Z 6071 followers, 7368 engagements


"$MLYS and $NKTR keep running strong after competitors data. Both with BO potential $MLYS +153% since $AZN data $NKTR +70% since $SNY data MLYS is preparing NDA NKTR still has to run ph3 Both are going after $4B++ market opportunities Happy to have both in my port"  
[X Link](https://x.com/Andre_AGTC/status/1965511613513187557) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-09-09T20:24Z 6066 followers, 14K engagements


"$PRAX Capital raise is well accepted. Stock is up to XXX from offering at XXX It follows the good tradition to gain after secondary following great data $ABVX XX from XX offering $NKTR XX from XXXXX offering I guess $PRAX will trade sooner or later at XXX to 300"  
[X Link](https://x.com/Andre_AGTC/status/1979182649684943163) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-17T13:48Z 6071 followers, 2763 engagements


"Update top 10+10 (after $VRNA BO) $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $VKTX metabolic $MIRM IBAT rare $MLTX I&I IL17A/F $SRRK TGFb $ALNY RNAi $RVMD RASmuti $BBIO $CRNX $CPRX $ABEO $KYMR $NUVL $IMCR $ACAD $CORT $NBIX"  
[X Link](https://x.com/Andre_AGTC/status/1945600827659264000) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-07-16T21:45Z 6071 followers, 32.7K engagements


"$RVMD Stifel with $XX PT Key from the note is: First revenue for RVMD in 1Q27 and global revenue of $11.3B by 2035 I had 6.5B in my model implying 13b MC 11B revenue may command 20B MC Today MC is 9.3B so still room to grow"  
[X Link](https://x.com/Andre_AGTC/status/1978565147892351460) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-15T20:54Z 6071 followers, 4852 engagements


"@a_a_free @A_May_MD @grok Agree novel MOA is a good selling point They may get aquired for the platform. I have Feb and May 2026 calls in both in case it happens But the field is crowded"  
[X Link](https://x.com/Andre_AGTC/status/1978632066045542408) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-16T01:20Z 6071 followers, XXX engagements


"$MLYS Strong cap raise at XXXXX (2 oversubscribed) Now trades at 2.1B MC with about 600M cash Next catalysts - NDA in q4. IMO they will be BO by the end of the year. Only open question is if the BO will be before or after NDA filing 3x since first recommended 5-6x at BO"  
[X Link](https://x.com/Andre_AGTC/status/1963682421083414665) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-09-04T19:15Z 6071 followers, 7120 engagements


"$VTGN Looks X is the new resistance Jan 4c are trending today. Someone is buing them fot XXXX. To make money the stock has to trade X which is +50% from today's price. Just saying"  
[X Link](https://x.com/Andre_AGTC/status/1975218208950112369) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-06T15:14Z 6069 followers, 1816 engagements


"@LTbioinvestor Agree about $CRNX and $KURA Don't know the other tickets $RNA looks early to enter"  
[X Link](https://x.com/Andre_AGTC/status/1966311106756145229) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-09-12T01:21Z 6066 followers, 1381 engagements


"$ACHV Awarded voucher for cytisinicline The first FDA Commissioner's National Priority Voucher (CNPV) pilot program The company still doesn't know it - no press release but the stock is already +40% 🤣 My Dec $X calls (see below) will triple overnight"  
[X Link](https://x.com/Andre_AGTC/status/1978984661012316594) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-17T00:41Z 6071 followers, 5149 engagements


"Opend a position in $JANX at XX Two data sets by the end of the year XXX mCPRX XXX EGFR solids RA capital owns XXXX% of the company Recently Point72 added 1.7M shares"  
[X Link](https://x.com/Andre_AGTC/status/1976295924600131771) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-09T14:37Z 6071 followers, 5302 engagements


"$GLUE Crossed XX a long term resistance Not only brake over XX but now XX in a week $ZVRA as well $KURA and $TRVI still in XX area but will follow soon IMO $XX is a key psychological # when crossed it propels the stock to XX. So many examples in my short investment time"  
[X Link](https://x.com/Andre_AGTC/status/1978586348958220471) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-15T22:18Z 6070 followers, 4933 engagements


"Sold XX% in $SNDX and got more $KURA Just based on ton of catalysts PDUFA Nov XX NPM AML Ph1b in KMT2A AML Both w their Menin inhibitor Ph1 in RCC and Oh1 in RAS Ph1/2 in HNSCC"  
[X Link](https://x.com/Andre_AGTC/status/1975350189809693105) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-06T23:59Z 6070 followers, 3747 engagements


"$SANA Big surprise my Black Swan trade Jan 2026 2.5c and 5c turned out to be not that stupid"  
[X Link](https://x.com/Andre_AGTC/status/1978465635756581293) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-15T14:19Z 6070 followers, 3046 engagements


"@A_May_MD "First" and "Only" drug in UC and AD sounds like an understatement of the year @grok list the Approved Drugs for Ulcerative Colitis and Atopic Dermatitis"  
[X Link](https://x.com/Andre_AGTC/status/1978593768249905415) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-15T22:48Z 6071 followers, 1488 engagements


"$CRNX Catysts near term Early Q4 PR palsonify is avalable Q4 obesity candidate Q1'26: TouCAHn cohort X data Q1'26: palsonify fist Q sales BO of Radionetics CRNX owns XX% They may not need to raise cash if the deal goes through 1.2B Cash may be enough for the launch but "  
[X Link](https://x.com/Andre_AGTC/status/1972321094737813935) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-09-28T15:22Z 6070 followers, 3582 engagements


"$CYBN XX% Drop on 4x the avg volume It looks a fund is getting out Major holders are Tang ( known for playing games) Deep Track and Pont72"  
[X Link](https://x.com/Andre_AGTC/status/1940561965086396666) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-07-03T00:03Z 6072 followers, 3298 engagements


"Many trade on margins and this happens Bios are a bit greener. Some of my top positions are green like $MDGL $RVMD $BBIO $MLYS. If I didn't sell $PTGX and $ABVX 2-3 weeks ago I would be selebrating today. $GLUE is a smallish posion can not compensate for these misses"  
[X Link](https://x.com/Andre_AGTC/status/1976855402559291708) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-11T03:40Z 6070 followers, 2057 engagements


"@BowTiedBiotech Good for them is that menin will finance the development of their new FTI $KURA w $850M MC and $630M cash - looks a safe long-term investment (if anything in biotech can be called safe 🙂)"  
[X Link](https://x.com/Andre_AGTC/status/1977370909611569334) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-12T13:48Z 6071 followers, XXX engagements


"$PRAX TAM is significant - about 7-8M ptnts in US alone For comparison $NBIX has $14B MC with 10-15% of that number in TD PRAX today even after a +200% gain is just $3.8B MC A lot of room to grow"  
[X Link](https://x.com/Andre_AGTC/status/1978864767633707057) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-16T16:45Z 6070 followers, 5271 engagements


"$CYBN The CEO is stepping down effective immediately. Eric So Cybins Co-Founder and President becomes Interim CEO Is it bc the GAD data are delayed from mid-2025 to q4"  
[X Link](https://x.com/Andre_AGTC/status/1962863568509948287) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-09-02T13:01Z 6071 followers, 4547 engagements


"$CYBN GAD data delayed Expect recruiting to complete in Aug Top line data in X weeks - mid to end Oct. Full data set in XX weeks - mid to end Dec"  
[X Link](https://x.com/Andre_AGTC/status/1956068284274761834) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-08-14T18:59Z 6071 followers, 2056 engagements


"$IDR $XX hello $PPTA and $IDR are profiting and will keep doing well in the current environment where USA is trying compensate for China total dominance"  
[X Link](https://x.com/Andre_AGTC/status/1978236472747581564) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-14T23:08Z 6069 followers, 3263 engagements


"$PRAX Innitial target population is 300-600k. At 20k/y it is peak rev 6-12B If it can be used prophylactically in mild cases the target is 2-3M ptnts. It may need additional trail for label expansion if the subgroup analysis is not enough to support Glass Scale I in the label"  
[X Link](https://x.com/Andre_AGTC/status/1978978866522714521) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-17T00:18Z 6071 followers, 4500 engagements


"$IDYA #ESMO25 abstract"  
[X Link](https://x.com/Andre_AGTC/status/1978099876001874174) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-14T14:05Z 6071 followers, 2048 engagements


"$IDYA Pipeline discussion on #ESMO25 in Berlin hosted by Cantor"  
[X Link](https://x.com/Andre_AGTC/status/1978100327762063631) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-14T14:07Z 6071 followers, 1924 engagements


"$KRYS Received FDA Platform Technology Designation (PTD) for HSV-1 Vector for the Neurotrophic Keratitis (NK) This new designation is great - KRYS can use manufacturing and safety data from VYJUVEK in the NDA A good news for biotech -FDA is getting more efficient"  
[X Link](https://x.com/Andre_AGTC/status/1978082640327495934) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-14T12:57Z 6070 followers, 1532 engagements


"A lot of drama this week to finish +/-0% Last two months were great - two big aquisitions ($VRNA & $BPMC) 6mo also incl $ITCI BO YTD return +107.7% So one or more weeks of consolidation is not a bad thing even if it last until the end of 2025"  
[X Link](https://x.com/Andre_AGTC/status/1946413573128786235) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-07-19T03:35Z 6071 followers, 13.8K engagements


"Sounds easy First in class with unique MOA and large TAM I had XX aquisition in my port in the last 2.5y and most of them fit this description From my current holding IMO $XENE $MDGL $KRYS $BBIO $RVMD $NKTR fit these requirements"  
[X Link](https://x.com/Andre_AGTC/status/1978264470129414324) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-15T00:59Z 6071 followers, 8728 engagements


"$KRYS VYJUVEK Label expansion Revised label allows the treatment of DEB patients from birth In addition it can be applied by patients and caregivers"  
[X Link](https://x.com/Andre_AGTC/status/1967571471531954469) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-09-15T12:49Z 6065 followers, 10K engagements


"@EgorBezel $NVTS short report published Aug XX 2025: A Short Thesis on Overvaluation Amid Tariff and Competitive Risks Since then the stock is exactly +100% Risk is real but short sellers typically try to make money by exaggerating it But instead of making money they lost"  
[X Link](https://x.com/Andre_AGTC/status/1978309294316515402) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-15T03:57Z 6069 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Andre_AGTC Avatar @Andre_AGTC Andre-ACGT

Andre-ACGT posts on X about $kura, $mdgl, stocks, $mlys the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

  • X Week XXXXXX +1.80%
  • X Month XXXXXXX -XX%
  • X Months XXXXXXXXX -XX%
  • X Year XXXXXXXXX +43%

Mentions: XX #

Mentions Line Chart

  • X Week XX -XX%
  • X Month XXX -XX%
  • X Months XXX -XX%
  • X Year XXXXX +80%

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX +0.25%
  • X Month XXXXX +1.70%
  • X Months XXXXX +13%
  • X Year XXXXX +22%

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence finance XXXX% stocks XXXX% currencies XXXX% countries XXXX%

Social topic influence $kura #1, $mdgl #1, stocks #2752, $mlys #2, $krys #1, $bbio #1, $rvmd #10, $glue #1, long term #213, $zvra #1

Top accounts mentioned or mentioned by @wallstsai @bowtiedbiotech @maximusholla @pharmdca @kingachillese @andreagtc @amaymd @jfais20 @biopharmiq @antisentiment_ @wshao8 @joserestonva @viewfromahill9 @oncinvestor @drrichjlaw @seedy19tron @grok @pjamess69 @jialiangliang @snupsnus

Top assets mentioned Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Mineralys Therapeutics, Inc. Common Stock (MLYS) Krystal Biotech, Inc. Common Stock (KRYS) BridgeBio Pharma, Inc. Common Stock (BBIO) Revolution Medicines, Inc. Common Stock (RVMD) Neurocrine Biosciences, Inc. (NBIX) Axsome Therapeutics, Inc (AXSM) Blueprint Medicines Corporation (BPMC) IDEAYA Biosciences, Inc. Common Stock (IDYA) Praxis Precision Medicines, Inc. Common Stock (PRAX) Crinetics Pharmaceuticals, Inc. (CRNX) Viking Therapeutics, Inc (VKTX) AstraZeneca PLC (AZN) Xenon Pharmaceuticals Inc (XENE) Mirum Pharmaceuticals, Inc. Common Stock (MIRM) Novartis AG (NVS) Novo-Nordisk (NVO) Akropolis (AKRO) Seagen Inc (SGEN) Karuna Therapeutics, Inc. Common Stock (KRTX) Gilead Sciences, Inc. (GILD) Summit Therapeutics Inc. Common Stock (SMMT) Synthetify (SNY) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Scholar Rock Holding Corporation Common Stock (SRRK) Alnylam Pharmaceuticals, Inc. (ALNY) Catalyst Pharmaceutical Inc. (CPRX) Kymera Therapeutics, Inc. Common Stock (KYMR) Acadia Pharmaceuticals Inc. (ACAD) Nuvalent, Inc. Class A Common Stock (NUVL) Corcept Therapeutics Inc. (CORT) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Avidity Biosciences, Inc. Common Stock (RNA) Janux Therapeutics, Inc. Common Stock (JANX) Tarsus Pharmaceuticals, Inc. Common Stock (TARS) ATAI Life Sciences (ATAI) Protagonist Therapeutics, Inc (PTGX) Perpetua Resources Corp. Common Shares (PPTA)

Top Social Posts #


Top posts by engagements in the last XX hours

"$GLUE X hello (holla is trademarked by @Maximus_Holla) Let's see if they brake XX which is long term resistance Some of my stocks are fighting with this round superstitious number. Typically key to propel the stock to XX $ZVRA $TRVI $KURA and soon $BCYC"
X Link @Andre_AGTC 2025-10-10T14:59Z 6071 followers, 6936 engagements

"$NBIX Long term efficacy and safety data in Huntington's Disease Chorea. It was approved in 2023. These results will potentially help with ramping the drug"
X Link @Andre_AGTC 2025-10-06T12:42Z 6069 followers, 1937 engagements

"@Bios_n_Techs @monaco_biotech $ZVRA confirmed the breakout. Next are $TRVI and $KURA to confirm"
X Link @Andre_AGTC 2025-10-09T19:19Z 6066 followers, XXX engagements

"$NVO aquires $AKRO in 5.2B deal Roche aquired $ETNB in Sep Cardio metabolic space is hot No position in both but the trend can go on hopefully with stock like $MDGL $MLYS $VKTX in which I have solid positions"
X Link @Andre_AGTC 2025-10-09T12:40Z 6066 followers, 1501 engagements

"@EgorBezel Infinion and STmicro are not real competitors bc they don't have the technology. Tariff is an issue we should watch. But XXX% Tariff is not visible"
X Link @Andre_AGTC 2025-10-15T04:24Z 6066 followers, XX engagements

"$KURA has X presentations on ESMO 2025 (Oct 17-21) with KO-2806 FTI (Farnesyltransferase Inhibitor) Mono is just safety. But combo w cabo in RCC may propel the stock if ORR XX% We have X catalysts w KURA - ESMO Oct XX + PDUFA Nov 30"
X Link @Andre_AGTC 2025-09-28T13:18Z 6070 followers, 3568 engagements

"$AXSM Executing the long term plan Already X drugs on the market X NDA in the next 2Q - ADA and narcolepcy Sitting solid on #2 in my portfolio. Historically what ever thicket is on #2 got aquitered: $SGEN $KRTX $BPMC $VRNA Let's see if $AXSM can keep the tradition alive"
X Link @Andre_AGTC 2025-08-22T14:43Z 6065 followers, 6373 engagements

"$KURA on #ESMO25 Three w farnesyl transferase inhibitor (FTI) KO-2806 w cabozantinib in RCC KO-2806 mono in RAS mutations Tipifarnib and alpelisib in PIK3CA-mutant HNSCC The most interesting are RCC data"
X Link @Andre_AGTC 2025-10-12T13:28Z 6071 followers, 7368 engagements

"$MLYS and $NKTR keep running strong after competitors data. Both with BO potential $MLYS +153% since $AZN data $NKTR +70% since $SNY data MLYS is preparing NDA NKTR still has to run ph3 Both are going after $4B++ market opportunities Happy to have both in my port"
X Link @Andre_AGTC 2025-09-09T20:24Z 6066 followers, 14K engagements

"$PRAX Capital raise is well accepted. Stock is up to XXX from offering at XXX It follows the good tradition to gain after secondary following great data $ABVX XX from XX offering $NKTR XX from XXXXX offering I guess $PRAX will trade sooner or later at XXX to 300"
X Link @Andre_AGTC 2025-10-17T13:48Z 6071 followers, 2763 engagements

"Update top 10+10 (after $VRNA BO) $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $VKTX metabolic $MIRM IBAT rare $MLTX I&I IL17A/F $SRRK TGFb $ALNY RNAi $RVMD RASmuti $BBIO $CRNX $CPRX $ABEO $KYMR $NUVL $IMCR $ACAD $CORT $NBIX"
X Link @Andre_AGTC 2025-07-16T21:45Z 6071 followers, 32.7K engagements

"$RVMD Stifel with $XX PT Key from the note is: First revenue for RVMD in 1Q27 and global revenue of $11.3B by 2035 I had 6.5B in my model implying 13b MC 11B revenue may command 20B MC Today MC is 9.3B so still room to grow"
X Link @Andre_AGTC 2025-10-15T20:54Z 6071 followers, 4852 engagements

"@a_a_free @A_May_MD @grok Agree novel MOA is a good selling point They may get aquired for the platform. I have Feb and May 2026 calls in both in case it happens But the field is crowded"
X Link @Andre_AGTC 2025-10-16T01:20Z 6071 followers, XXX engagements

"$MLYS Strong cap raise at XXXXX (2 oversubscribed) Now trades at 2.1B MC with about 600M cash Next catalysts - NDA in q4. IMO they will be BO by the end of the year. Only open question is if the BO will be before or after NDA filing 3x since first recommended 5-6x at BO"
X Link @Andre_AGTC 2025-09-04T19:15Z 6071 followers, 7120 engagements

"$VTGN Looks X is the new resistance Jan 4c are trending today. Someone is buing them fot XXXX. To make money the stock has to trade X which is +50% from today's price. Just saying"
X Link @Andre_AGTC 2025-10-06T15:14Z 6069 followers, 1816 engagements

"@LTbioinvestor Agree about $CRNX and $KURA Don't know the other tickets $RNA looks early to enter"
X Link @Andre_AGTC 2025-09-12T01:21Z 6066 followers, 1381 engagements

"$ACHV Awarded voucher for cytisinicline The first FDA Commissioner's National Priority Voucher (CNPV) pilot program The company still doesn't know it - no press release but the stock is already +40% 🤣 My Dec $X calls (see below) will triple overnight"
X Link @Andre_AGTC 2025-10-17T00:41Z 6071 followers, 5149 engagements

"Opend a position in $JANX at XX Two data sets by the end of the year XXX mCPRX XXX EGFR solids RA capital owns XXXX% of the company Recently Point72 added 1.7M shares"
X Link @Andre_AGTC 2025-10-09T14:37Z 6071 followers, 5302 engagements

"$GLUE Crossed XX a long term resistance Not only brake over XX but now XX in a week $ZVRA as well $KURA and $TRVI still in XX area but will follow soon IMO $XX is a key psychological # when crossed it propels the stock to XX. So many examples in my short investment time"
X Link @Andre_AGTC 2025-10-15T22:18Z 6070 followers, 4933 engagements

"Sold XX% in $SNDX and got more $KURA Just based on ton of catalysts PDUFA Nov XX NPM AML Ph1b in KMT2A AML Both w their Menin inhibitor Ph1 in RCC and Oh1 in RAS Ph1/2 in HNSCC"
X Link @Andre_AGTC 2025-10-06T23:59Z 6070 followers, 3747 engagements

"$SANA Big surprise my Black Swan trade Jan 2026 2.5c and 5c turned out to be not that stupid"
X Link @Andre_AGTC 2025-10-15T14:19Z 6070 followers, 3046 engagements

"@A_May_MD "First" and "Only" drug in UC and AD sounds like an understatement of the year @grok list the Approved Drugs for Ulcerative Colitis and Atopic Dermatitis"
X Link @Andre_AGTC 2025-10-15T22:48Z 6071 followers, 1488 engagements

"$CRNX Catysts near term Early Q4 PR palsonify is avalable Q4 obesity candidate Q1'26: TouCAHn cohort X data Q1'26: palsonify fist Q sales BO of Radionetics CRNX owns XX% They may not need to raise cash if the deal goes through 1.2B Cash may be enough for the launch but "
X Link @Andre_AGTC 2025-09-28T15:22Z 6070 followers, 3582 engagements

"$CYBN XX% Drop on 4x the avg volume It looks a fund is getting out Major holders are Tang ( known for playing games) Deep Track and Pont72"
X Link @Andre_AGTC 2025-07-03T00:03Z 6072 followers, 3298 engagements

"Many trade on margins and this happens Bios are a bit greener. Some of my top positions are green like $MDGL $RVMD $BBIO $MLYS. If I didn't sell $PTGX and $ABVX 2-3 weeks ago I would be selebrating today. $GLUE is a smallish posion can not compensate for these misses"
X Link @Andre_AGTC 2025-10-11T03:40Z 6070 followers, 2057 engagements

"@BowTiedBiotech Good for them is that menin will finance the development of their new FTI $KURA w $850M MC and $630M cash - looks a safe long-term investment (if anything in biotech can be called safe 🙂)"
X Link @Andre_AGTC 2025-10-12T13:48Z 6071 followers, XXX engagements

"$PRAX TAM is significant - about 7-8M ptnts in US alone For comparison $NBIX has $14B MC with 10-15% of that number in TD PRAX today even after a +200% gain is just $3.8B MC A lot of room to grow"
X Link @Andre_AGTC 2025-10-16T16:45Z 6070 followers, 5271 engagements

"$CYBN The CEO is stepping down effective immediately. Eric So Cybins Co-Founder and President becomes Interim CEO Is it bc the GAD data are delayed from mid-2025 to q4"
X Link @Andre_AGTC 2025-09-02T13:01Z 6071 followers, 4547 engagements

"$CYBN GAD data delayed Expect recruiting to complete in Aug Top line data in X weeks - mid to end Oct. Full data set in XX weeks - mid to end Dec"
X Link @Andre_AGTC 2025-08-14T18:59Z 6071 followers, 2056 engagements

"$IDR $XX hello $PPTA and $IDR are profiting and will keep doing well in the current environment where USA is trying compensate for China total dominance"
X Link @Andre_AGTC 2025-10-14T23:08Z 6069 followers, 3263 engagements

"$PRAX Innitial target population is 300-600k. At 20k/y it is peak rev 6-12B If it can be used prophylactically in mild cases the target is 2-3M ptnts. It may need additional trail for label expansion if the subgroup analysis is not enough to support Glass Scale I in the label"
X Link @Andre_AGTC 2025-10-17T00:18Z 6071 followers, 4500 engagements

"$IDYA #ESMO25 abstract"
X Link @Andre_AGTC 2025-10-14T14:05Z 6071 followers, 2048 engagements

"$IDYA Pipeline discussion on #ESMO25 in Berlin hosted by Cantor"
X Link @Andre_AGTC 2025-10-14T14:07Z 6071 followers, 1924 engagements

"$KRYS Received FDA Platform Technology Designation (PTD) for HSV-1 Vector for the Neurotrophic Keratitis (NK) This new designation is great - KRYS can use manufacturing and safety data from VYJUVEK in the NDA A good news for biotech -FDA is getting more efficient"
X Link @Andre_AGTC 2025-10-14T12:57Z 6070 followers, 1532 engagements

"A lot of drama this week to finish +/-0% Last two months were great - two big aquisitions ($VRNA & $BPMC) 6mo also incl $ITCI BO YTD return +107.7% So one or more weeks of consolidation is not a bad thing even if it last until the end of 2025"
X Link @Andre_AGTC 2025-07-19T03:35Z 6071 followers, 13.8K engagements

"Sounds easy First in class with unique MOA and large TAM I had XX aquisition in my port in the last 2.5y and most of them fit this description From my current holding IMO $XENE $MDGL $KRYS $BBIO $RVMD $NKTR fit these requirements"
X Link @Andre_AGTC 2025-10-15T00:59Z 6071 followers, 8728 engagements

"$KRYS VYJUVEK Label expansion Revised label allows the treatment of DEB patients from birth In addition it can be applied by patients and caregivers"
X Link @Andre_AGTC 2025-09-15T12:49Z 6065 followers, 10K engagements

"@EgorBezel $NVTS short report published Aug XX 2025: A Short Thesis on Overvaluation Amid Tariff and Competitive Risks Since then the stock is exactly +100% Risk is real but short sellers typically try to make money by exaggerating it But instead of making money they lost"
X Link @Andre_AGTC 2025-10-15T03:57Z 6069 followers, XXX engagements

creator/x::Andre_AGTC
/creator/x::Andre_AGTC